CMS Innovation

Regulatory Issues September 22, 2021

Medicare Coverage of Innovative Technologies (MCIT)

By Dr. Lee A. Fleisher – CMS is committed to ensuring people on Medicare have quicker access to innovative medical technologies for life-threatening or irreversibly debilitating diseases – like cancer and heart disease. In January 2021, we published a final rule called The Medicare Coverage of Innovative Technology and Definition of ‘Reasonable and Necessary’ (MCIT/R&N).

News, Regulatory Issues March 3, 2015

Participation in CMS Oncology Care Model Requires MU Attestation

On February 12, HHS announced a new multi-payer payment and care delivery model to support better care coordination for cancer care as part of the Department’s ongoing efforts to improve the quality of care patients receive and spend health care dollars more wisely, contributing to healthier communities.